AI for Biomaterials and Drug Design

Symposium Co-Chairs

Key Speakers

DeepChem: Towards Open Source Foundations for Modern Drug Discovery
Bharath Ramsundar
CEO, Deep Forest Sciences

Karl Leswing
Senior Director, Machine Learning
Schrodinger

Small Molecule Generation with Property Control via Disentangled Representation Learning
Amarda Shehu
Professor, George Mason University

Advances in computational power coupled with big data analysis and innovations in machine learning, modeling and simulation approaches are enabling artificial intelligence to revolutionize the biomaterials and drug discovery and development process.

Submit your abstract and join researchers from around the world as we highlight the latest developments in this area.

SPONSORS & PARTNERS

2022 SBIR/STTR AGENCY PARTNERS